Northstar Advisory Group Boosts McKesson Holdings

Investment firm increases stake in pharmaceutical distributor by over 130%

Mar. 31, 2026 at 10:34am

Got story updates? Submit your updates here. ›

Northstar Advisory Group LLC, an investment management firm, has significantly increased its holdings in McKesson Corporation (NYSE: MCK), a major pharmaceutical distribution and healthcare services company. According to a recent SEC filing, Northstar raised its stake in McKesson by 133.4% during the fourth quarter of 2025.

Why it matters

This move by Northstar Advisory Group suggests the firm sees strong potential in McKesson's business and future performance. As one of the largest healthcare distribution companies in the U.S., McKesson's financial health and growth are closely watched by investors and analysts.

The details

In its 13F filing, Northstar Advisory Group reported owning 3,704 shares of McKesson stock as of the end of the fourth quarter, up from 1,587 shares held previously. This increased the firm's total investment in McKesson to $3.04 million. The filing indicates Northstar was actively acquiring additional McKesson shares during the quarter to boost its position in the company.

  • Northstar Advisory Group filed its 13F report for the fourth quarter of 2025 on March 31, 2026.
  • The firm increased its McKesson holdings during the fourth quarter of 2025.

The players

Northstar Advisory Group LLC

An investment management firm that has significantly increased its stake in pharmaceutical distributor McKesson Corporation.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to closely monitor McKesson's performance and growth potential as a key player in the healthcare distribution industry.”

— Danessa Lincoln, Financial Analyst

The takeaway

Northstar Advisory Group's substantial increase in its McKesson holdings suggests the firm sees the pharmaceutical distributor as a strong investment opportunity, underscoring McKesson's importance and growth prospects within the broader healthcare supply chain.